Five Prime Therapeutics Inc is a listed company. Its directors and officers file their transactions with SEC (Form 4). No insider at Five Prime Therapeutics Inc has published a filing in the past twelve months. The most recent one dates from 8 February 2016.
Over the whole record (from 2016), the tally stands at no purchases and 13 sales.
Elsewhere in the same market, our signals recently picked up insider purchases at GameStop Corp. and Heico Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
FY ended December 2020 · cache
25 of 25 declarations
Five Prime Therapeutics Inc is a biopharmaceutical company focused on developing innovative therapies for the treatment of cancer and other serious diseases. It is listed on NASDAQ under the ticker FPRX.
Purchases our model currently ranks for the recommendations list.
All recommendations